Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease

Physiological Research

Volumn 52, Issue 4, 2003, Pages 433-437

  Merta, Miroslav ^a   Reiterova J ^a   Rysava R ^a   Tesar V ^a   Zavada J ^a   Jachymova M ^a   Zima, T ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Arterial hypertension; Autosomal dominant polycystic kidney disease; Chronic renal failure; Endothelin; Nitric oxide

Indexed keywords

ENDOTHELIN; NITRATE; NITRIC OXIDE; NITRITE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; MALE; PATHOGENESIS;

ADULT; AGED; ANTIOXIDANTS; CHRONIC DISEASE; CREATINE; ENDOTHELIN-1; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; LIPID PEROXIDATION; MALE; MIDDLE AGED; NITRIC OXIDE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 0041425318     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. AMANN K, SIMONAVICIENE A, MEDWEDEWA T, KOCH A, ORTH S, GROSS ML, HAAS C, KUHLMANN A, LINZ W, SCHOLKENS B, RITZ E: Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage. J Am Soc Nephrol 12: 2572-2584, 2001.
2. BENIGNI A, REMUZZI G: How renal cytokines and growth factors contribute to renal disease progression. Am J Kidney Dis 37 (Suppl 2): S21-S24, 2001.
3. CRKOVSKÁ J., ŠTÍPEK S: Factors influencing the determination of nitrites and nitrates in serum using nitrate reductase and Griess reagente (in Czech). Klin Biochem Metab 6: 82-87, 1998.
4. GIUSTI R, NERI M, ANGELINI D, CARLINI A, FIORINI I, BIGONGIARI P, ANTONELLI A: Plasma concentration of endothelin and arterial pressure in patients with ADPKD. Contrib Nephrol 115: 119-121, 1995.
5. HOCHER B, ZART R, BRAUN N, SCHWARZ A, VAN DER WOUDE F, ROHMEISS P, KOPPENHAGEN K: The Endothelin system in polycystic kidneys of Han:SPRD rats. J Cardiovasc Pharmacol 31 (Suppl 1): S342-S344, 1998a.
6. HOCHER B, ZART R, SCHWARZ A, VOGT V, BRAUN C, THONE-REINEKE C, BRAUN N, NEUMAYER HH, KOPPENHAGEN K, BAUER C, ROHMEISS P: Renal endothelin system in polycystic kidney disease. J Am Soc Nephrol 9: 1169-1177, 1998b.
7. HORKÝ K: Patophysiological role of endothelin in cardiovascular diseases and the possibilities of its blockade (in Czech). Remedia 8: 408-413, 1998.
8. KLAHR S: The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant 16 (Suppl 1): 60-62, 2001.
9. MERTA M, ZIMA T, ŠTÍPEK S, CRKOVSKÁ J, PLÁTENÍK J: Lipid peroxidation and activity of superoxide dismutase in ADPKD. Contrib Nephrol 115: 109-112, 1995.
10. MUNEMURA C, UEMASU J, KAWASAKI H: Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: possible evidence of heterogeneity in cystogenesis. Am J Kidney Dis 24: 561-568, 1994.
11. NAICKER S, BHOOLA KD: Endothelins: vasoactive modulators of renal function in health and disease. Pharmacol Ther 90: 61-88, 2001.
12. REITEROVÁ J, MERTA M, TESAŘ V, ŠTEKROVÁ J: Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease. Kidney Blood Press Res 25: 87-90, 2002.
13. SEEMAN T, VONDRICHOVA H, STRIZOVA J, SIKUT M, JANDA J, SCHARER K: Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease. Cas Lek Ces 138: 178-184, 1999.
14. SCHICHIRI M, HIRATA Y, EMORI T: Secretion of endothelin and related peptides from renal epithelial cell lines. FEBS Lett 253: 203-206, 1989.
15. TORRES VE, DONOVAN KA, SCICLI G, HOLLEY KE, THIBODEAU SN, CARRETERO OA, INAGAMI T, MCATEER JA, JOHNSON CM: Synthesis of renin by tubulocystic epithelium in autosomal dominant polycystic kidney disease. Kidney Int 42: 364-373, 1992.
16. WANG D, IVERSEN J, STRANDGAARD S: Contractility and endothelium-dependent relaxation of resistance vessels in polycystic kidney disease in rats. J Vasc Res 36: 502-509, 1999.
17. WANG D, IVERSEN J, STRANDGAARD S: Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11: 1371-1376, 2000.
18. YOKOZAWA T, CHUNG HY, KIM DW, GOTO H: Involvement of superoxide and/or nitric oxide in renal tissue injury. Exp Toxicol Pathol 59: 517-521, 1999.
19. YOSHIDA I, BENGAL R, TORRES VE: Gender-dependent effect of L-NAME on polycystic kidney disease in Han:SPRD rats. Am J Kidney Dis 35: 930-936, 2000.